InnovAge Holding to Pay $36M to Resolve Allegations of False Claims Act, State Law Violations

Dow Jones11-18 02:34
 

InnovAge Holding agreed to pay $36 million to resolve allegations that it violated federal and state laws by failing to provide medical services and referrals as quickly as necessary to address its senior patients' health conditions.

InnovAge receives Medicare and Medicaid funding to provide healthcare services to seniors at centers across several states. According to the Justice Department, the Denver-based company did not maintain sufficient specialist provider networks and often failed to timely schedule appointments or consultations for specialist medical care for its patients in areas like oncology, cardiology, surgery and neurology, for a period between 2016 and 2022.

As a result, it failed to keep up with the requirements of the dual Medicare-Medicaid program it provides those services under, violating the federal False Claims Act as well as state laws, the Department of Justice said.

The settlement is not a determination of liability.

A spokesperson for InnovAge said the company has worked closely with the Centers for Medicare and Medicaid Services and its state government partners while investing to strengthen its clinical operations, compliance infrastructure and care delivery capabilities.

"Resolving these historical allegations from 2016 to 2022, with no admission of wrongdoing, allows us to move forward with a continued focus on delivering high-quality, compassionate care to the frail seniors we serve," the spokesperson said.

With the settlement, InnovAge will pay about $25.7 million to the U.S. and a combined $10.3 million to Colorado, California, New Mexico and Virginia.

 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment